Notification

🚨 Trading Holiday 🚨

The NSE and BSE will remain closed for trading and settlement on Friday, April 18, 2025, on account of Good Friday.

Open a Free Demat Account

Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.

Trade Now, Pay Later with up to 4x

Never miss a good trading opportunity due to low funds with our MTF feature.

Track Market Movers Instantly

Stay updated with real-time data. Get insights at your fingertips.

NSE BSE

Trade Nowopens in a new tab

Sun Pharma Adv.res.co.ltd Share Price

₹ 150.9 0.53 (0.35%)

Apr 17 2025 01:48 PM Pharmaceuticals NSE: SPARC

Sun Pharma Adv.res.co.ltd Share Price Update

As of the latest trading session, Sun Pharma Adv.res.co.ltd share price is currently at 150.9, which is up by 0.53 from its previous closing. Today, the stock has fluctuated between 148.33 and 152.32. Over the past year, Sun Pharma Adv.res.co.ltd has achieved a return of -59.19 %. In the last month alone, the return has been 28.23 %. Read More...

Sun Pharma Adv.res.co.ltd Performance

Day Range

Low148.33 High152.32

151.14

52 Week Range

Low 109.30 High 387.85

151.14

Sun Pharma Adv.res.co.ltd Share Price

14788

532872

SPARC

Compare to down-arrow

View

Display

Studies

No Data Available

Open Price

150.36 Prev. Close

150.36 Volume (Shares)

361946.00

Total traded value

547.04 Upper Circuit

180.43 Lower Circuit

120.28

Note: The current prices & values are delayed, Loginopens in a new tab to your account for live updates.

Sun Pharma Adv.res.co.ltd Fundamentals

(Standalone)

Market Cap (Cr)	4897.03
PE Ratio (TTM)	-12.47
Book Value / Share	3.84
Beta	1.22

ROE	0.00%
EPS (TTM)	0.00
Dividend Yield	0.00%
Net Profit Qtr (Cr)	-79.71

Sun Pharma Adv.res.co.ltd Financials

Key Results
Key Ratios
Balance sheet
Cash Flow
Competition

Revenue

Net income

Particulars	DEC 2024 (Values in Cr)
Revenue	14.91
Operating Expense	94.81
Net Profit	-79.71
Net Profit Margin (%)	-534.60
Earnings Per Share (EPS)	-2.46
EBITDA	-74.19
Effective Tax Rate (%)	0.00

Particulars	SEP 2024 (Values in Cr)
Revenue	12.86
Operating Expense	120.59
Net Profit	-107.69
Net Profit Margin (%)	-837.40
Earnings Per Share (EPS)	-3.32
EBITDA	-103.81
Effective Tax Rate (%)	0.00

Particulars	JUN 2024 (Values in Cr)
Revenue	16.81
Operating Expense	115.21
Net Profit	-96.84
Net Profit Margin (%)	-576.08
Earnings Per Share (EPS)	-2.98
EBITDA	-93.56
Effective Tax Rate (%)	0.00

Particulars	MAR 2024 (Values in Cr)
Revenue	16.56
Operating Expense	127.64
Net Profit	-106.69
Net Profit Margin (%)	-644.26
Earnings Per Share (EPS)	-3.29
EBITDA	-103.12
Effective Tax Rate (%)	0.00

Particulars	DEC 2023 (Values in Cr)
Revenue	13.86
Operating Expense	119.90
Net Profit	-99.65
Net Profit Margin (%)	-718.97
Earnings Per Share (EPS)	-3.07
EBITDA	-96.23
Effective Tax Rate (%)	0.00

Particulars	MAR 2024 (Values in Cr)
Revenue	75.55
Operating Expense	493.13
Net Profit	-388.11
Net Profit Margin (%)	-513.71
Earnings Per Share (EPS)	-11.96
EBITDA	-374.32
Effective Tax Rate (%)	0.00

Particulars	MAR 2023 (Values in Cr)
Revenue	238.78
Operating Expense	472.24
Net Profit	-222.58
Net Profit Margin (%)	-93.21
Earnings Per Share (EPS)	-7.82
EBITDA	-203.18
Effective Tax Rate (%)	0.00

Particulars	MAR 2022 (Values in Cr)
Revenue	137.25
Operating Expense	347.49
Net Profit	-203.40
Net Profit Margin (%)	-148.19
Earnings Per Share (EPS)	-7.73
EBITDA	-179.91
Effective Tax Rate (%)	0.00

Particulars	MAR 2021 (Values in Cr)
Revenue	252.96
Operating Expense	409.51
Net Profit	-151.14
Net Profit Margin (%)	-59.74
Earnings Per Share (EPS)	-5.77
EBITDA	-129.57
Effective Tax Rate (%)	0.00

Particulars	MAR 2020 (Values in Cr)
Revenue	76.82
Operating Expense	398.98
Net Profit	-312.40
Net Profit Margin (%)	-406.66
Earnings Per Share (EPS)	-11.92
EBITDA	-300.24
Effective Tax Rate (%)	0.00

Particulars	MAR 2024 (Values in Cr)
Book Value / Share	3.88
ROE %	0.00
ROCE %	0.00
Total Debt to Total Equity	0.12
EBITDA Margin	-493.22

Particulars	MAR 2023 (Values in Cr)
Book Value / Share	15.80
ROE %	0.00
ROCE %	0.00
Total Debt to Total Equity	0.03
EBITDA Margin	-85.09

Particulars	MAR 2024 (Values in Cr)
Book Value / Share	3.85
ROE %	0.00
ROCE %	0.00
Total Debt to Total Equity	0.11
EBITDA Margin	-495.46

Particulars	MAR 2023 (Values in Cr)
Book Value / Share	15.80
ROE %	0.00
ROCE %	0.00
Total Debt to Total Equity	0.17
EBITDA Margin	-85.09

Particulars	MAR 2022 (Values in Cr)
Book Value / Share	-7.47
ROE %	0.00
ROCE %	0.00
Total Debt to Total Equity	0.00
EBITDA Margin	-131.07

Particulars	MAR 2021 (Values in Cr)
Book Value / Share	-6.42
ROE %	0.00
ROCE %	0.00
Total Debt to Total Equity	0.00
EBITDA Margin	-51.22

Particulars	MAR 2020 (Values in Cr)
Book Value / Share	-0.71
ROE %	0.00
ROCE %	0.00
Total Debt to Total Equity	0.25
EBITDA Margin	-390.90

Particulars	MAR 2024 (Values in Cr)
Cash & Short Term Investments	155.32
Total Assets	515.04
Total Liabilities	515.04
Total Equity	125.75
Share Outstanding	324521588
Price to Book Ratio	96.09
Return on Assets (%)	-75.18
Return on Capital (%)	-224.14

Particulars	MAR 2023 (Values in Cr)
Cash & Short Term Investments	111.57
Total Assets	830.12
Total Liabilities	830.12
Total Equity	512.77
Share Outstanding	324521588
Price to Book Ratio	11.36
Return on Assets (%)	-26.81
Return on Capital (%)	-43.4

Particulars	MAR 2024 (Values in Cr)
Cash & Short Term Investments	155.06
Total Assets	486.33
Total Liabilities	486.33
Total Equity	124.85
Share Outstanding	324521588
Price to Book Ratio	96.09
Return on Assets (%)	-79.80
Return on Capital (%)	-225.83

Particulars	MAR 2023 (Values in Cr)
Cash & Short Term Investments	111.57
Total Assets	830.12
Total Liabilities	830.12
Total Equity	512.77
Share Outstanding	324521588
Price to Book Ratio	11.36
Return on Assets (%)	-26.81
Return on Capital (%)	-43.4

Particulars	MAR 2022 (Values in Cr)
Cash & Short Term Investments	1.22
Total Assets	280.08
Total Liabilities	280.08
Total Equity	31.22
Share Outstanding	271878966
Price to Book Ratio	-39.74
Return on Assets (%)	-72.61
Return on Capital (%)	-191.47

Particulars	MAR 2021 (Values in Cr)
Cash & Short Term Investments	9.31
Total Assets	229.68
Total Liabilities	229.68
Total Equity	-168.25
Share Outstanding	262047506
Price to Book Ratio	-22.07
Return on Assets (%)	-65.80
Return on Capital (%)	-242.62

Particulars	MAR 2020 (Values in Cr)
Cash & Short Term Investments	0.45
Total Assets	272.56
Total Liabilities	272.56
Total Equity	-18.63
Share Outstanding	262047506
Price to Book Ratio	-135.92
Return on Assets (%)	-114.61
Return on Capital (%)	-654.39

Particulars	MAR 2024 (Values in Cr)
Net Income	-386.83
Cash from Operations	-425.07
Cash from Investing	391.52
Cash from Financing	42.40
Net change in Cash	4.74
Free Cash Flow	-398.56

Particulars	MAR 2023 (Values in Cr)
Net Income	-222.58
Cash from Operations	-74.48
Cash from Investing	-548.27
Cash from Financing	616.75
Net change in Cash	-0.64
Free Cash Flow	-59.09

Particulars	MAR 2024 (Values in Cr)
Net Income	-388.10
Cash from Operations	-425.31
Cash from Investing	391.11
Cash from Financing	42.79
Net change in Cash	4.47
Free Cash Flow	-398.80

Particulars	MAR 2023 (Values in Cr)
Net Income	-222.58
Cash from Operations	-74.48
Cash from Investing	-548.27
Cash from Financing	616.75
Net change in Cash	-0.64
Free Cash Flow	-59.09

Particulars	MAR 2022 (Values in Cr)
Net Income	-203.39
Cash from Operations	-212.77
Cash from Investing	-29.16
Cash from Financing	229.32
Net change in Cash	-8.07
Free Cash Flow	-180.09

Particulars	MAR 2021 (Values in Cr)
Net Income	-151.13
Cash from Operations	-150.26
Cash from Investing	1.56
Cash from Financing	159.28
Net change in Cash	8.95
Free Cash Flow	-144.26

Particulars	MAR 2020 (Values in Cr)
Net Income	-312.40
Cash from Operations	-200.94
Cash from Investing	155.34
Cash from Financing	55.46
Net change in Cash	0.00
Free Cash Flow	-146.90

Company Name	Price	P/E	P/B	Market Cap	52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L	38.88	20.90	2.12	297.95	34.11 / 77.70
BLISS GVS PHARMA LTD	123.15	16.14	1.28	1297.63	92.25 / 184.95
CIPLA LTD	1496.50	24.22	4.26	120859.90	1310.05 / 1702.00
FERMENTA BIOTECH LIMITED	275.00	22.78	2.78	809.35	145.00 / 449.00

Company Name	Price	P/E	P/B	Market Cap	52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L	38.88	23.42	6.61	297.95	34.11 / 77.70
AMRUTAJAN HEALTH LTD	683.10	40.04	6.63	1974.89	548.05 / 861.40
ASTRAZENECA PHARMA IND LT	8511.00	126.94	31.32	21277.50	5000.00 / 9101.00
BLISS GVS PHARMA LTD	123.15	15.99	1.26	1297.63	92.25 / 184.95

Technicals

EMA & SMA
Resistance and Support
Price Change Analysis

Bullish Moving Averages -

Bearish Moving Averages -

5 Days 147.30
26 Days 143.40
10 Days 146.20
50 Days 147.60
12 Days 145.70
100 Days 164.20
20 Days 143.90
200 Days 189.00

150.04
PIVOT

First Resistance	152.27
Second Resistance	154.19
Third Resistance	156.42

First Support	148.12
Second Support	145.89
Third Support	143.97

RSI	57.83
MACD	2.32
Commodity Channel Index (CCI)	61.77

ADX	37.35
Williams % R	-32.69

Sun Pharma Adv.res.co.ltd Future

Future: Price

25 May

0 100 200 300 400 500 600

Discount/Premium

25 May

0 1 2 3 4 5 6 7

Active Calls

25 May

0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul

0 500 1000 1500 2000 2500

Stock Holding

View Live Stock Screeners

Holding

Public

31.46 Promoter Holdings

65.67 FII

2.22 DII

0.63 Promoter Shares(Pledge Percentage)

0.0

Name	Category	Shares	Shares%
Shanghvi Finance Private Limited	Shareholding of Promoter and Promoter Group	1.37211787E8	42.28
Dilip Shantilal Shanghvi	Shareholding of Promoter and Promoter Group	6.181066E7	19.05
Sun Pharmaceutical Industries Key Employees Benefit Trust	Public Shareholding	1.0317377E7	3.18
Lakshdeep Investments & Finance (p) Ltd.	Public Shareholding	6033835.0	1.86
Rekha Jhunjhunwala	Public Shareholding	5164000.0	1.59
Aditya Medisales Limited	Shareholding of Promoter and Promoter Group	4888126.0	1.51
Raksha S.valia	Shareholding of Promoter and Promoter Group	4145231.0	1.28
Vijay Mohanlal Parekh	Public Shareholding	3661304.0	1.13
Paresh Mohanlal Parekh	Public Shareholding	3646837.0	1.12
Enam Securities Private Limited	Public Shareholding	3370786.0	1.04
Sudhir Valia	Shareholding of Promoter and Promoter Group	1833951.0	0.57
Unimed Investments Limited	Shareholding of Promoter and Promoter Group	1267963.0	0.39
Vibha Dilip Shanghvi	Shareholding of Promoter and Promoter Group	1063236.0	0.33
Vidhi Dilip Shanghvi	Shareholding of Promoter and Promoter Group	344081.0	0.11
Aalok Dilip Shanghvi	Shareholding of Promoter and Promoter Group	350162.0	0.11
Shanghvi Family & Friends Benefit Trust (kumud S. Shanghvi And Dilip S. Shanghvi)	Shareholding of Promoter and Promoter Group	154922.0	0.05
Kumud S. Shanghvi	Shareholding of Promoter and Promoter Group	38795.0	0.01
Gujarat Sun Pharmaceutical Industries Pvt Ltd	Shareholding of Promoter and Promoter Group	1751.0	0.0
Sanghvi Properties Private Limited	Shareholding of Promoter and Promoter Group	1887.0	0.0
Flamboyawer Finance Private Limited	Shareholding of Promoter and Promoter Group	2543.0	0.0

Sun Pharma Adv.res.co.ltd

Ex-Date	Dividend Amt.	Dividend Type	Record Date	Instrument Type

Learn More About Stocks

Zydus Lifesciences Invests in Feldan to Boost Drug Delivery Innovation

Zydus Lifesciences’ VC arm Zynext Ventures invests in Canada’s Feldan Therapeutics to advance innovation in intracellular drug delivery technologies.

17 Apr, 2025 | 3 Min. read

DLF To Sell Kolkata IT SEZ To Srijan Group For Rs.693 Crore

DLF Ltd to sell its 25.9-acre Kolkata IT SEZ, including DLF Tech Park, to Srijan Group for Rs.693 crore through a slump sale.

17 Apr, 2025 | 3 Min. read

UltraTech Cement Acquires 26% Stake in Solar SPV for Rs.25.5 Crore

UltraTech Cement to invest Rs.25.5 crore for a 26% stake in AMPIN C&I Power Eight to secure green energy for operations and reduce power costs.

17 Apr, 2025 | 3 Min. read

BHEL Signs Tech Deal With BARC to Cut Green Hydrogen Costs

BHEL partners with BARC to adopt indigenous diaphragm technology for electrolysers, aiming to cut green hydrogen costs and reduce import dependency.

17 Apr, 2025 | 2 Min. read

CCI Approves Aster DM–Quality Care Merger; New Entity Named Aster DM Quality Care

CCI clears merger of Aster DM Healthcare and Quality Care India Ltd, forming Aster DM Quality Care Ltd. Combined entity to operate 38 hospitals with 10,150 beds.

16 Apr, 2025 | 3 Min. read

ICICI Lombard Q4 Profit Falls 1.9%, Declares ₹7 Final Dividend

ICICI Lombard Q4 net profit declines by 1.9% YoY to ₹509.6 crore, while FY25 PAT jumps 30.7%. Board declares ₹7 final dividend, total ₹12.5 for FY25.

16 Apr, 2025 | 3 Min. read

IndusInd Bank Finds ₹1,979 Crore Net Worth Hit in Derivatives Audit

An external audit reveals ₹1,979 crore impact on IndusInd Bank’s net worth due to derivative discrepancies. Bank to reflect changes in FY25 financial reports.

16 Apr, 2025 | 2 Min. read

Oil India Wins 9 Blocks in OALP Round-IX, Acreage Jumps 85%

Oil India secures 9 exploration blocks in OALP Round-IX, expanding its acreage by 85% to 1.10 lakh sq km. ONGC, Cairn, and BP also win key bids.

16 Apr, 2025 | 3 Min. read

Dr Reddy’s Denies Workforce Reduction Claims Amid Cost-Cut Rumours

Dr Reddy’s Laboratories rejects claims of reducing workforce costs by 25%, asserting no such plans or internal directives.

15 Apr, 2025 | 3 Min. read

Glenmark, Sun Pharma, Zydus Recall Drugs in US over Compliance Issues

Glenmark, Sun Pharma, and Zydus recall multiple drug batches in the US following manufacturing deviations and contamination concerns as per USFDA enforcement reports.

15 Apr, 2025 | 3 Min. read

About Sun Pharma Adv.res.co.ltd

Companies Owned by Sun Pharma Adv.res.co.ltd

We have something for everyone

Explore More Investment Options

Start Investing

Stocks

Secure and enhance your financial future today

Invest

IPOs

Your gateway to future financial opportunities

Invest

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x

Invest

US Stocks

Discover opportunities to invest in elite FAANG stocks

Invest

Frequently Asked Questions

What is the Share Price of Sun Pharma Advanced Research Company Ltd?

Answer Field: The share price of Sun Pharma Advanced Research Company Ltd for NSE is ₹ 150.9 and for BSE is ₹ 150.7.

What is the Market Cap of Sun Pharma Advanced Research Company Ltd?

Answer Field: The market cap of Sun Pharma Advanced Research Company Ltd for NSE is ₹ 48,97.03 Cr. and for BSE is ₹ 48,90.54 Cr. as of now.

What is the 52 Week High and Low of Sun Pharma Advanced Research Company Ltd?

Answer Field: The 52 Week High and Low of Sun Pharma Advanced Research Company Ltd for NSE is ₹ 368.45 and ₹ 109.30 and for BSE is ₹ 369.65 and ₹ 109.20.

How to Buy Sun Pharma Advanced Research Company Ltd share?

Answer Field: You can trade in Sun Pharma Advanced Research Company Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Sun Pharma Advanced Research Company Ltd?

Answer Field: The 1 year returns on the stock has been -59.19%.

What is the Current Share Price of Sun Pharma Advanced Research Company Ltd?

Answer Field: Sun Pharma Advanced Research Company Ltd share price is for NSE ₹ 150.9 & for BSE ₹ 150.7 as on Apr 17 2025 01:48 PM.

What is the Market Cap of Sun Pharma Advanced Research Company Ltd Share?

Answer Field: The market cap of Sun Pharma Advanced Research Company Ltd for NSE ₹ 48,97.03 & for BSE ₹ 48,90.54 as on Apr 17 2025 01:48 PM.

What is the P/E Ratio of Sun Pharma Advanced Research Company Ltd Share?

Answer Field: As on Apr 17 2025 01:48 PM the price-to-earnings (PE) ratio for Sun Pharma Advanced Research Company Ltd share is -12.47.

What is the PB ratio of Sun Pharma Advanced Research Company Ltd Share?

Answer Field: As on Apr 17 2025 01:48 PM, the price-to-book (PB) ratio for Sun Pharma Advanced Research Company Ltd share is 3.84.

How to Buy Sun Pharma Advanced Research Company Ltd Share?

Answer Field: You can trade in Sun Pharma Advanced Research Company Ltd shares with Bajaj Broking by opening a demat accountopens in a new tab.

How to Buy Sun Pharma Advanced Research Company Ltd Share on Bajaj Broking App?

Answer Field

To buy Sun Pharma Advanced Research Company Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Sun Pharma Advanced Research Company Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Scan to download

Download from App Store

Download from Play Store

9.5 lakh+ Users

4+ App Rating

4 Languages

₹4400+ Cr MTF Book

Open Demat Account

🚨 Trading Holiday 🚨

Open a Free Demat Account

Trade Now, Pay Later with up to 4x

Track Market Movers Instantly

Sun Pharma Adv.res.co.ltd Share Price

Sun Pharma Adv.res.co.ltd Share Price Update

Sun Pharma Adv.res.co.ltd Performance

Day Range

52 Week Range

Sun Pharma Adv.res.co.ltd Share Price

Open Price

150.36

Prev. Close

150.36

Volume (Shares)

361946.00

Total traded value

547.04

Upper Circuit

180.43

Lower Circuit

120.28

Sun Pharma Adv.res.co.ltd Fundamentals

Sun Pharma Adv.res.co.ltd Financials

Revenue

Net income

Technicals

Over 1 Month

28.23

Over 3 Months

-15.62

Over 6 Months

-29.50

Over 1 Year

-59.19

Over 3 Years

-18.75

Over 5 Years

1.62

Sun Pharma Adv.res.co.ltd Future

Future: Price

Discount/Premium

Active Calls

Active Puts

Sun Pharma Adv.res.co.ltd Shareholding Pattern

Stock Holding

View Live Stock Screeners

Holding

Public

31.46

Promoter Holdings

65.67

FII

2.22

DII

0.63

Promoter Shares(Pledge Percentage)

0.0

Holding %

Pledges % of promoter shares %

MF Holding %

FII Holding %

Sun Pharma Adv.res.co.ltd

Learn More About Stocks

Zydus Lifesciences Invests in Feldan to Boost Drug Delivery Innovation

DLF To Sell Kolkata IT SEZ To Srijan Group For Rs.693 Crore

UltraTech Cement Acquires 26% Stake in Solar SPV for Rs.25.5 Crore

BHEL Signs Tech Deal With BARC to Cut Green Hydrogen Costs

About Sun Pharma Adv.res.co.ltd

Companies Owned by Sun Pharma Adv.res.co.ltd

Explore More Investment Options

Stocks

IPOs

MTF

US Stocks

Frequently Asked Questions

What is the Share Price of Sun Pharma Advanced Research Company Ltd?

What is the Market Cap of Sun Pharma Advanced Research Company Ltd?

What is the 52 Week High and Low of Sun Pharma Advanced Research Company Ltd?

How to Buy Sun Pharma Advanced Research Company Ltd share?